Immunocore Holdings PLC
NASDAQ:IMCR

Watchlist Manager
Immunocore Holdings PLC Logo
Immunocore Holdings PLC
NASDAQ:IMCR
Watchlist
Price: 34.17 USD 1.24% Market Closed
Market Cap: 1.7B USD
Have any thoughts about
Immunocore Holdings PLC?
Write Note

Wall Street
Price Targets

IMCR Price Targets Summary
Immunocore Holdings PLC

Wall Street analysts forecast IMCR stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for IMCR is 82.4 USD with a low forecast of 66.66 USD and a high forecast of 105 USD.

Lowest
Price Target
66.66 USD
95% Upside
Average
Price Target
82.4 USD
141% Upside
Highest
Price Target
105 USD
207% Upside

IMCR Last Price Targets
Immunocore Holdings PLC

The latest public price target was made on Oct 24, 2024 by David Dai from UBS , who expects IMCR stock to drop by 30% over the next 12 months. You can read more about this price target by viewing the article on StreetInsider.

Analyst Price Target Date Article
David Dai
UBS
24 USD
Downside 30%
3 weeks ago
Oct 24, 2024
UBS Starts Immunocore Holdings (IMCR) at Sell
StreetInsider
Justin Kim
Oppenheimer
89 USD
Upside 160%
1 month ago
Sep 16, 2024
Oppenheimer Reiterates Outperform Rating on Immunocore Holdings (IMCR)
StreetInsider
Graig Suvannavejh
Mizuho Securities
72 USD
Upside 111%
2 months ago
Sep 12, 2024
Mizuho Reiterates Outperform Rating on Immunocore Holdings (IMCR)
StreetInsider
Patrick Trucchio
H.C. Wainwright
100 USD
Upside 193%
2 months ago
Aug 28, 2024
H.C. Wainwright Reiterates Buy Rating on Immunocore Holdings (IMCR)
StreetInsider
Peter Lawson
Barclays
66 USD
Upside 93%
3 months ago
Aug 9, 2024
Immunocore price target lowered to $66 from $92 at Barclays
TheFly
Graig Suvannavejh
Mizuho Securities
88 USD
Upside 158%
6 months ago
May 13, 2024
Immunocore Holdings (IMCR) PT Lowered to $88 at Mizuho
StreetInsider
Bill Maughan
Canaccord Genuity
67 USD
Upside 96%
6 months ago
May 9, 2024
Immunocore Holdings (IMCR) PT Raised to $67 at Canaccord Genuity
StreetInsider
Show More Price Targets
Show Less Price Targets
David Dai
UBS
Price Target 24 USD
Upside/Downside 30%
View Source
Justin Kim
Oppenheimer
Price Target 89 USD
Upside/Downside 160%
View Source
Graig Suvannavejh
Mizuho Securities
Price Target 72 USD
Upside/Downside 111%
View Source
Patrick Trucchio
H.C. Wainwright
Price Target 100 USD
Upside/Downside 193%
View Source
Peter Lawson
Barclays
Price Target 66 USD
Upside/Downside 93%
View Source
Graig Suvannavejh
Mizuho Securities
Price Target 88 USD
Upside/Downside 158%
View Source
Bill Maughan
Canaccord Genuity
Price Target 67 USD
Upside/Downside 96%
View Source
Show More Price Targets
Show Less Price Targets
Immunocore Holdings PLC Competitors:
Price Targets
TSVT
2Seventy Bio Inc
104% Upside
300653
Yantai Zhenghai Bio-Tech Co Ltd
27% Upside
IMRX
Immuneering Corp
569% Upside
AVTE
Aerovate Therapeutics Inc
10% Downside
4593
Healios KK
86% Upside
9926
Akeso Inc
5% Upside
BBIO
BridgeBio Pharma Inc
97% Upside
688278
Xiamen Amoytop Biotech Co Ltd
1% Upside

Revenue
Forecast

Revenue Estimate
Immunocore Holdings PLC

For the last 4 years the compound annual growth rate for Immunocore Holdings PLC's revenue is 77%. The projected CAGR for the next 3 years is 16%.

77%
Past Growth
16%
Estimated Growth
N/A
Estimates Accuracy
N/A
Average

Operating Income
Forecast

Operating Income Estimate
Immunocore Holdings PLC

N/A
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average

Net Income
Forecast

Net Income Estimate
Immunocore Holdings PLC

N/A
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average

See Also

Discover More
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is IMCR's stock price target?
Price Target
82.4 USD

According to Wall Street analysts, the average 1-year price target for IMCR is 82.4 USD with a low forecast of 66.66 USD and a high forecast of 105 USD.

What is Immunocore Holdings PLC's Revenue forecast?
Projected CAGR
16%

For the last 4 years the compound annual growth rate for Immunocore Holdings PLC's revenue is 77%. The projected CAGR for the next 3 years is 16%.

Back to Top